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ABSTRACT 
 
DEV J. NAIR 
State Medicaid Agencies Approaches to Quality Improvement: Implications for Policy, 
Practice and Health Outcomes 
(Under the direction of Russ Toal, Faculty Member) 
 
Medicaid provides coverage to approximately 60 million individuals and is the largest 
single payer of healthcare for children.  Given this scope of the program and the 
concentration of low-income and minority recipients, improvements to the quality of care 
delivered to Medicaid members represents a significant opportunity to reduce health care 
disparities and improve the overall delivery and quality of healthcare within the U.S.  The 
current study sought to evaluate the various approaches that state Medicaid agencies are 
taking to assess and improve the quality of care to their managed care enrollees and the 
degree to which they have implemented recommendations of various policy experts.  
 
A survey was distributed to the Medicaid Directors of all 50 states.  A total of 23 states 
with risk based managed care programs responded, representing 62% of the states that 
have managed care programs.  The results indicated that nearly all states are utilizing 
standard performance measures as one method to assess quality, with virtually all relying 
on HEDIS measures for this purpose.  Additional strategies that are being used include 
public reporting of quality data and the use of pay-for-performance incentives; few states 
are currently focusing on health information technology.  Recommendations are made for 
steps that the Medicaid program could take at both the state and federal level to further 
develop quality improvement programs.   
 
 
Index Words: Medicaid, Managed Care, Quality Improvement, Performance 
Measurement, Pay for Performance, HEDIS.
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I. INTRODUCTION 
Medicaid was enacted in 1965 as Title XIX of the Social Security Act to provide 
medical assistance to low income families, and aged and disabled individuals receiving 
welfare benefits.  Medicaid was designed as a federal and state partnership, with the 
federal government establishing broad guidelines related to eligibility requirements and 
minimum covered services.  In return states receive matching funds of 50 to 76 percent of 
their Medicaid expenditures (Kaiser Family Foundation, 2008 and 2009).     
In 1967 Medicaid was expanded from a program that merely provided assistance 
for diagnosed medical conditions to one that focused on the promotion of the healthy 
growth and development of children.  The Early Periodic Screening, Diagnostic, and 
Treatment (EPSDT) program established requirements for assuring that children covered 
by Medicaid received comprehensive preventive health, screening, and follow-up 
(Rosenbaum, Mauery, Shin, & Hidalgo, 2005).   
With eligibility requirements initially linked to the receipt of welfare payments, 
Medicaid enrollments began to decline as states restricted requirements for Aid to 
Families with Dependent Children (AFDC) in the 1970s and 80s.  These reductions in 
Medicaid coverage, along with reports of rising infant mortality rates, led to 
congressional action to broaden access and coverage provisions for children and pregnant 
women, and to tie eligibility requirements to family income, as opposed to the receipt of 
welfare benefits (Mann, Rowland, & Garfield, 2003).    
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In an effort to contain escalating health care costs, to attain greater accountability 
for access to care, and to improve the  quality of health care services, state Medicaid 
agencies began to contract with managed care organizations to provide services to 
recipients.  Such contracts began in the 1980’s, with enrollment into managed care plans 
further expanding in 1997 with the passage of the Balanced Budget Act (BBA) that 
allowed the mandatory enrollment of certain population groups without obtaining a 
waiver through the Centers for Medicare and Medicaid Services (CMS) ("Balanced 
Budget Act of 1997,"; Kaiser Family Foundation, 2008; Mann et al., 2003).   
Despite efforts to expand access to quality health care for low income individuals, 
significant disparities in access to care and health care outcomes continue to persist 
(Agency for Healthcare Research and Quality, 2008).  These disparities exist across 
racial, ethnic, and socio-economic dimensions (Agency for Healthcare Research and 
Quality, 2008), as well as across states and geographic regions (Shea, Davis, & Schor, 
2008), and between individuals that have commercial health care coverage as opposed to 
Medicaid coverage (Landon et al., 2007).   
Medicaid provides coverage to approximately 60 million individuals (Smith, 
Ellis, Edwards, & Rudowitz, 2009), of whom about 44 million are low income children 
and their parents (Kaiser Family Foundation, 2009).  Medicaid is the largest single payer 
of healthcare for children, covering nearly 25% (Kaiser Commission on Medicaid and the 
Uninsured, 2006; Kaiser Family Foundation, 2009).  Additionally, Medicaid is 
responsible for nearly 20% of all health care expenditures, covering over one of every 3 
births, and over 40% of long-term care expenses (Kaiser Family Foundation, 2009)  
Given this scope of the program and the concentration of low-income and minority 
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recipients, improvements to the quality of care delivered to Medicaid members represents 
a significant opportunity to reduce health care disparities and improve the overall 
delivery and quality of healthcare within the United States. 
The number of Medicaid enrollees covered by some type of managed care plan 
has been steadily increasing, with over 65% covered by managed care as of June 2006 
(Finance Systems and Budget Group, 2006).  Contracting with managed health care 
organizations (MCOs) provides opportunities to hold these organizations accountable for 
achieving specific goals related to access and quality.  This contractual accountability is 
one of the key tools that can be used to drive improvements in quality, and an advantage 
when compared with trying to improve quality through a traditional system in which the 
state directly reimburses providers for their services (Highsmith & Somers, 2000).   
However, the literature on the impact of managed care on improved quality for 
Medicaid recipients has been mixed.  Some studies have found improvements in quality 
such as increased use of controller medication and attendance at routine physician office 
visits by asthmatics (Bollinger, Smith, LoCasale, & Blaisdell, 2007); and reductions in 
hospitalizations for ambulatory sensitive conditions such as asthma and diabetes (Landon 
& Epstein, 1999).  Conversely, other studies have found decreases in the quality of care 
subsequent to the implementation of managed care including increases in the number of 
mental health readmissions (Fontanella, Zuravin, & Burry, 2006); and decreases in the 
initiation of early prenatal care along with corresponding increases in the rate of 
premature births, low-birth weight infants, and neonatal mortality (Aizer, Currie, & 
Moretti, 2007). 
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The ability of states to hold MCOs accountable for improvements in quality is 
dependent in part on having performance based contracts and developing effective 
mechanisms of oversight (Fossett et al., 2000).  In surveying state Medicaid agencies 
regarding their oversight of managed health care plans, Landon, Tobias, and Epstein 
(1998) found that few states were collecting systematic performance data on satisfaction, 
access, or quality measures, or reporting significant improvements in quality.  Likewise, 
they also found few states that were reporting comparative data to either their health 
plans or their enrollees.  They suggest that while there are many challenges that states 
face in improving quality health care for Medicaid enrollees, there also are significant 
resources that states can leverage.  These include the ability to compel changes through 
regulation, as well as the ability to require (through contracting) the collection of 
performance data and cooperation between health plans.   
Corrigan, Eden, and Smith (2002) reviewed a number of strategies that they 
believed were crucial for government agencies to maintain better oversight over quality.  
Among their recommendations were: 
• Purchasing strategies that encourage adoption of best practices through the 
public release of comparative data and rewards for performance; 
• Establishing standardized measurement and reporting practices across 
various government programs; 
• Making comparative quality data available in a variety of formats to meet 
the needs of different users (researchers, recipients, accreditors, 
purchasers, advocates, etc.); 
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• Establishing core sets of standard performance measures; and 
• Greater standardization across state Medicaid and SCHIP programs with 
respect to quality measures and reporting.  
While there has been much growth and maturation of Medicaid managed care 
programs over the past five to ten years, there is little systematic data on the approaches 
used to measure and improve the quality of care, or on the impact that these approaches 
have had in actual improvements in clinical processes or outcomes.  This study examines 
and updates the prior research that has evaluated approaches that states have used for 
monitoring and improving the quality of care delivered through managed care 
organizations.  Specifically it investigates the degree to which prior recommendations 
have been implemented, and whether there is an association between implementation of 
these practices and improvements in quality.  Finally, this paper concludes with 
recommendations for future steps that CMS and state Medicaid agencies can take to 
continue to improve of the quality of health care delivered to their recipients. 
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II. REVIEW OF LITERATURE 
Health Care Quality 
Over the years quality researchers have come up with a variety of definitions and 
concepts for measuring health care quality.  Donabedian (1967) was one of the first to 
focus on the concept of quality specific to health care, describing it in terms of structure, 
process, and outcome.   
Structure refers to the setting in which health care occurs and includes things such 
as the type and qualifications of the practitioner providing the care; the configuration of 
the organization providing the care; specific medical policies governing the provision of 
card; as well as various mechanisms to monitor and/or reward specific processes or 
outcomes.   
Process refers to the implementation of specific practices that are known (or 
believed) to lead to specific health outcomes.   A number of organizations publish 
evidence based practices (EBP); practices that are supported by the weight of research 
evidence to be effective in treating a specific condition.  Thus quality assessment may 
focus on the extent to which these processes are consistently implemented.   
While structure and process focus on whether certain elements thought to lead to 
good health care are present, they do not automatically result in good outcomes.  Thus 
measurement of actual results, such as the number of patients that survive a heart attack, 
or the rate of infant mortality, is important as well.   
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Brook, McGlynn, & Cleary (1996) have suggested that for structure and process 
variables to be credible, one must show that changes in either the structure or the process 
result in differences in outcome.  For example, research showing that the use of beta 
blockers after a heart attack results in lower mortality lends credibility to a measure of 
whether or not beta blockers are administered as an indicator of quality.  Thus one 
method of assessing quality is evaluating certain process of care against an ideal criterion, 
such as that specified in a practice guideline.   
Another method for assessing quality described by Brook et al (1996) is to 
compare actual clinical outcomes of a specific provider, organization, or health plan with 
the outcomes that would be expected under excellent, average, or poor care.  For 
example, research may have found that in a population of type II diabetics receiving 
excellent care, one can expect that 95% will have normal glycosylated hemoglobin, while 
with average care only 75% will have normal levels.  The actual outcomes can then be 
compared with these criteria to determine the level of quality of care delivered by a 
specific provider.  
Brook et al (1996) suggest that in may circumstances measures of process criteria 
may be more accurate than measures that look solely at outcome.  They note that patients 
can have good outcomes even when they do not receive the standard of care.  In addition, 
the outcomes for some conditions, such as diabetic retinopathy, may not become evident 
for many years.  They argue that the areas where outcome measures will be most 
appropriate are those in which there is strong evidence that the processes that can be 
controlled by the physician lead to different outcomes; where these processes may be 
difficult to measure (such as complex surgical procedures); and where there is a short 
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interval between the process and the outcome.  They suggest that risk adjusted mortality 
rates following coronary artery bypass surgery is one example of appropriate use of 
outcome measures.   
The Institute of Medicine (IOM) defined quality of care as “…the degree to which 
health services for individuals and populations increase the likelihood of desired health 
outcomes and are consistent with current professional knowledge” (Institute of Medicine, 
1990).  The IOM has further concluded that the quality of health care can be defined with 
a level of accuracy equal to many measures of clinical medicine.  However, while health 
care can be superb, in many instances it falls short of this, resulting in loss of life, 
reduced functioning, and inefficient use of resources.  These problems stem from the 
overuse, underuse, and misuse of medical care (Institute of Medicine, 1998).  They argue 
for an approach that combines elements of regulation, quality improvement, and 
marketplace strategies to improve the quality of health care.  
Medicaid Quality 
Studies evaluating the quality of care and service received by Medicaid recipients 
has suggested that the overall quality is low and that it lags behind the quality of care 
received by individuals covered by commercial insurance (Landon et al., 2007; 
Thompson, Ryan, Pinidiya, & Bost, 2003).   In a recent study, Landon et al (2007) 
evaluated performance on a number of Healthcare Effectiveness Data Information Set 
(HEDIS) measures to determine if there were differences in quality between commercial 
managed care plans, managed care plans that served both commercial and Medicaid 
members, and managed care plans that served only Medicaid members.  They found that 
members covered under commercial insurance had much higher quality scores than 
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members covered by Medicaid.  The quality scores for Medicaid recipients did not differ 
between those served by Medicaid only plans, as opposed to those that served both 
Medicaid and commercial populations.  Thus, the authors suggest that the characteristics 
of the health plan itself are less important than characteristics of the population, the 
specific provider networks that are providing care, the patterns of seeking care, and the 
degree to which individuals follow treatment recommendations.  They note that the 
differences in quality between members in commercial versus Medicaid plans were both 
statistically and clinically significant, and that raising the performance in Medicaid plans 
to that of commercial plans could result in several thousand fewer deaths annually.   
Variations Across States 
Shea, Davis, and Schor (2008) found that there are significant variations in the 
quality and access to health care for children across the country.  According to their 
analysis there are leading states that consistently perform better on multiple indicators of 
child health; these states typically have lower rates of uninsured children.  The authors 
suggest that from this standpoint Medicaid and the State Children’s Health Insurance 
Program (SCHIP) play a significant role in providing increased access to health care 
services for low income children, noting that with the enactment of SCHIP, the number 
of states with more than 16% of their children uninsured has decreased from 12 to five.  
They conclude that having better access to care and higher rates of insurance are 
associated with better quality, noting that states with the lowest rates of un-insured have 
higher rates of preventive care and better performance on other child health indicators.  
However, having health care by itself does not guarantee quality, and there are also 
significant variations among states within their Medicaid population.  
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Along with differences in the quality of care received by Medicaid members in 
general, studies have also found that there is significant variation in quality between 
Medicaid recipients in different states.  Ramírez de Arellano and Wolfe (2007) evaluated 
state Medicaid programs in terms of their eligibility requirements, the scope of services 
covered, quality of care, and reimbursement for providers.  They concluded that overall, 
state Medicaid programs have significant opportunities for improvement, with the highest 
scoring state rating 645.9 points on a scale of 1000.  They found significant discrepancies 
between state Medicaid programs, with the lowest scoring state achieving half the points 
of the highest scoring state.  The discrepancies related to quality were even more striking, 
with a seventeen fold difference between the highest and lowest scoring states.  
Ramírez de Arellano and Wolfe (2007) conclude that there are no standard quality 
measures that are used across all states, thus comparisons between states is difficult.  
Their study evaluated areas such as whether the state had mandatory requirements for 
reporting quality information, such as medical errors; measures of nursing home care, 
including the percentage of facilities with deficiencies related to quality of care; data on 
children receiving recommended immunizations, and children with emotional problems 
that received mental health care.  Due to the lack of standard Medicaid measures of 
quality, some of the data they evaluated (such as immunization rates) was state-wide, 
regardless of insurance coverage and thus represent a proxy for the quality of care 
delivered under Medicaid.  The authors conclude that their findings argue for the need to 
redefine “quality control” as it pertains to Medicaid programs, noting that The Centers for 
Medicare and Medicaid Services (CMS) currently require the monitoring of only 
eligibility determinations, which relate to fiscal rather than quality of care outcomes.  
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While CMS does not have significant requirements related to quality monitoring 
of services provided under traditional Medicaid programs, they do have a number of 
requirements for programs that contract with risk based managed care organizations.  
Some of these requirements will be discussed further in the sections that follow.    
Managed Medicaid and Impact on Quality 
The number of Medicaid recipients in managed care programs has continued to 
increase, from approximately 14% in 1991 (Highsmith & Somers, 2000) to 65% in 2006 
(Office of the Inspector General, 2008).  In 2008 over 30% of states increased the use of 
managed care, either through the inclusion of persons with disabilities, expanding into 
new geographic service areas, or requiring enrollment in managed care plans where it had 
previously been voluntary (Smith et al., 2008).  As noted earlier, state Medicaid programs 
began to shift toward contracting with managed care organizations as a means of both 
controlling escalating health care costs and improving access to care and the quality of 
care.  The impact of managed care on improving overall quality has been mixed, with 
some studies finding that the greater accountability has led to improvements in quality, 
while others have found that shifts in the traditional patterns of care and disruptions in the 
structure of traditional safety net providers may have led to disruptions in care that has 
had a negative impact on quality.  
Bollinger et al. (2007) evaluating the impact of shifting from a traditional fee-for-
service model to a managed care model, reported that this shift was associated with an 
improvement in the utilization of services by children with asthma.  Specifically they 
found that over a four year period there was an increase in routine office visits, decreases 
in emergency room and hospital admissions for asthma care, and corresponding increases 
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in the use of inhaled corticosteroids, reflecting better use of controller (as opposed to 
rescue) medications.  This study used as its baseline, the first year of managed care, and 
tracked improvement over the four year period from 1997 to 2000.  Thus while the study 
documented improvements in care over time following implementation of a managed 
care program, there were no direct comparisons to the utilization of services prior to the 
implementation of managed care.  The authors conclude that some of the factors that may 
have led to these improvements included more effective asthma case management, better 
access to and use of preventive care visits, improved specialty care access, and increased 
use of peak flow meters.  However, their study design did not allow conclusions as to 
whether these factors were related to improvement, or what role the managed care 
organization, or state Medicaid agency may have played.   
Cotter et al (2000) examined the impact of different types of managed care 
arrangements on the rates of immunizations in Medicaid covered children.  Specifically 
the looked at differences between recipients that were enrolled in a primary care case 
management program (PCCM), a voluntary managed care program, and a mandatory 
managed care program.  Recipients in a PCCM program are covered through the 
traditional fee-for-service Medicaid program, however, they are assigned to a primary 
care physician who is responsible for providing a medical home and coordinating their 
medical care services.  The study found that immunization rates were highest for 
individuals enrolled in the PCCM program and lowest in the mandatory managed care 
program.  However, while the study findings suggested that type of managed care 
program impacted the rate of immunization, they could not rule out other subject factors 
since the different programs served different geographic regions of the state, with the 
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PCCM program being active in both rural and urban areas and the two managed care 
programs serving two different urban areas.  The authors concluded that regardless of the 
type of plan, all immunization rates were below the Healthy People 2010 goals and that 
continued quality improvement efforts are essential.  They noted that improved outcomes 
will require monitoring by the state Medicaid agency to assure performance by managed 
care programs.  
Another study on the impact of implementing managed care for the Maryland 
Medicaid program found that the rate of re-hospitalization for mental illness increased in 
the year following managed care, when compared with the previous year (Fontanella et 
al., 2006).  The researchers examined changes in the rate of mental health readmissions 
for adolescents that were hospitalized during the year before implementation of a 
managed care program, and those hospitalized in the year following implementation.  
They found that while the overall rate of readmission was not significantly greater in the 
year following implementation of managed care, the proportion of adolescents with 
multiple readmissions increased, with the proportion of those having three or more 
readmissions more than doubling.   The authors suggest that this increase in multiple 
readmissions may reflect shorter hospital lengths of stay, with patients being discharged 
before they were stable, along with diminished community resources to provide ongoing 
outpatient care.  They note that a number of safety net providers experienced significant 
financial and administrative challenges following the impact of managed care which may 
have adversely affected their ability to provide care.  However, like many studies 
evaluating the impact of managed care in Medicaid, this study only evaluated the initial 
year of managed care implementation.  Thus it is not possible to assess the degree to 
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which maturation of the program, along with continued and perhaps more rigorous 
oversight by the state Medicaid agency may lead to improvements in quality.  
Aizer, Currie, and Moretti (2007) found that the implementation of mandatory 
managed care for California Medicaid recipients was associated with decreases in the 
initiation of timely prenatal care, and increases in the rate of neonatal mortality, low birth 
weight and premature birth.  They hypothesized that the emphasis of managed care 
companies on reducing costs and utilization, led to a decrease in access to physicians, as 
well as shifts towards hospitals with lower costs but poorer outcomes.  They note that 
under the program design, most of the managed care plans were not responsible for 
paying for the subsequent health care costs of infants that required intensive care, or other 
costly medical services.  Thus, they suggest that the program design (and the services an 
MCO is responsible for) can have a significant impact on the resultant quality and 
outcomes.  
State Oversight of Managed Medicaid Plans 
Authors have suggested a number of ways that Medicaid agencies can utilize 
arrangements with managed care organizations to improve the quality of health care.  
Among the tools available to agencies are contractual requirements to meet specific 
quality or access goals; requirements for conducting performance improvement projects, 
the use of performance measurement in conjunction with specific financial or non-
financial incentives and/or the public reporting of such data.  There has been much 
attention recently to the use of “pay for performance” incentives, or value based 
purchasing as techniques for improving health care quality, although to date there have 
been mixed results as to its effectiveness. 
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Verdier and Hurley (2004) note that performance measurement of managed health 
plans is a fundamental requirement for state Medicaid agencies exerting oversight over 
the provision of health care services.  While the nature and use of this data may vary with 
the maturity of the program and the context within which it operates, they identify several 
recommendations for Medicaid agencies to use in oversight of health plans.   
Public Reporting 
The authors suggest that ongoing evaluation and reporting is essential both to 
drive improvements in quality and to demonstrate accountability and credibility with 
external stakeholders.  Among their conclusions, Verdier and Hurley (2004) suggest that 
public reporting of data can be an important tool, provided that the data is credible and 
that it is tailored to meet the different needs and understanding of different audiences.  
For example, they suggest that health plan staff are more familiar with, and will make 
better use of complex health data, than will legislators, recipients, or the media.  They 
report that the states that they surveyed used a variety of performance measures, 
including encounter data, member complaints and grievances, provider participation, 
HEDIS and Consumer Assessment of Healthcare Providers and Systems (CAHPS) data, 
External Quality Review Organization (EQRO) reports, and MCO financial reports.    
Their data suggested a greater comfort and acceptance with the public reporting of 
standardized data such as HEDIS and CAHPS measures, as opposed to financial 
measures.  They also note that there is variation among states as to whether plan specific 
data is reported publicly, but suggest that such specific reporting may be more effective 
in improving performance when health plans feel that there is a need to compete with 
each other to achieve higher enrollments.  
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In a review of empirical literature, Fung, Lim, Mattke, Damberg, and Shekelle 
(2008) found mixed evidence supporting a link between public reporting of data and 
improvements in quality, or selection of a health plan.  Their review identified two 
randomized controlled trials both of which found no impact on the public reporting of 
patient satisfaction data from the CAHPS and the selection of a health plan.  However, 
they cite other studies that found consumers reported being willing to accept health plans 
with less generous coverage if those plans had higher satisfaction ratings, and that 
consumers were more likely to switch from plans with lower reported quality.  They 
found no studies that linked reporting of health plan performance data and quality 
improvement activity.  They cited one study that found health plans voluntarily reporting 
performance data (HEDIS and CAHPS measures) outperformed plans that did not report 
this data.  However, such findings could likely result from plans with better performance 
being more likely to choose to report their data. 
Similar to the conclusions of Verdier and Hurley (2004) Fung et al. (2008) 
suggest that for public reporting to be successful in improving quality, it is important that 
the reporting system be designed to achieve a specific purpose.  Thus if the goal of a 
reporting system is to assist consumers in choosing a health plan, then information must 
be presented in ways that are comprehensible and relevant to their selection.  
Contractual Requirements 
One of the ways that states are theoretically able to achieve improvements in 
quality through the use of managed care arrangements is by holding MCOs contractually 
accountable for achieving certain performance goals.  These may include requirements 
related to accessibility of providers, as well as achieving specific levels of improvement 
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in quality of care.  Fossett et al. (2000) suggest that states must do three things in order to 
be “prudent” purchasers of health care: 1) they must be able to specify their requirements 
for performance in a measurable form; 2) they need to have a mechanism to identify 
whether or not plans are complying with these requirements; and 3) there must be 
consequences for the failure of plans to achieve these requirements.  
In a survey of the practices at five states that had managed care contracts, the 
authors found that most states were not effectively utilizing these tools to achieve 
improvements in performance (Fossett et al., 2000).  They found that states had few 
specific performance requirements for quality, and where specific standards did exist, 
there was often no penalty for failure to achieve the goal.  The authors suggest that 
becoming a prudent purchaser of health care is a complex task requiring significant 
investment in data quality and systems for oversight.   Additionally, while most states 
have requirements for performance data, this has not consistently been analyzed or used 
to improve quality.   
Performance Measurement 
The use of specific strategies to drive quality improvement has been evolving 
over time, as state Medicaid managed care programs have become more mature.  Studies 
have found that while few states had any quality management activities in place in 1995, 
by 2001, most were collecting some performance data related to satisfaction, access, or 
quality (Landon, Schneider, Tobias, & Epstein, 2004).  In a survey of state Medicaid 
agencies, Landon et al. (2004) found that oversight of managed care plans has been 
increasing, but that opportunities for further improvement exist.  Similar to the findings 
of  Fossett et al. (2000), they found that while more states were collecting performance 
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data, few states were specifying specific minimum standards for quality measures 
(immunization rates were the exception).  They also found that while there was an 
increase in the reporting of comparative performance data, this was generally reported 
directly to health plans, rather than to recipients or to the public.  In addition, Landon et 
al (2004) found that there had been little increase in the number of states that had 
specifically targeted areas for improvement, although they did find that the number of 
states reporting that improvement had occurred had increased from four in 1995, to 10 in 
1998, and 17 in 2001.  Finally, they found that while approximately one-third of states 
had some sort of incentive or penalty system in place in 2001, in practice it was rarely 
utilized.   They conclude that while the monitoring of managed care plans by states was 
steadily increasing from 1995 to 2001, to be effective in improving quality, data will need 
to be tied to specific incentives and penalties (both financial and non-financial) for 
achieving specific quality goals.   
Performance Improvement Projects and Quality Collaboratives 
One of the tools for improving the quality of care is through a performance 
improvement project (PIP).  CMS describes the purpose of a PIP as “…to assess and 
improve processes, and thereby outcomes, of care.” (Centers for Medicare & Medicaid 
Services, 2002a).  According to CMS a PIP should focus on topics that are likely to 
impact a significant portion of enrollees and are likely to have a substantial impact on 
health, functional status, or satisfaction.  PIPs should address a specific study question, 
through the collection of valid data on a representative sample of the population in 
question.  Analysis of this data is used to generate hypotheses about current barriers to 
improvement and potential interventions.  These interventions are implemented with 
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subsequent measurement to determine whether improvement has occurred and if so, 
ongoing actions must assure the sustainability of these changes.  
Performance improvement projects represent a methodical approach to evaluating 
the current status of a health care process or outcome and implementing interventions 
focused on improving this process or outcome.  Under the BBA, PIPs are required by 
managed care organizations serving Medicaid enrollees, and they must be validated by an 
external quality review organization (EQRO).  Thus the use of PIPs represent another 
strategy that state Medicaid agencies can utilize to effect improvement in quality of care 
and service.  
Performance Improvement Projects can be done individually by each managed 
care organization in a state, conducted collaboratively with other MCOs and stakeholders 
within the state, or across different states.    Gold, Krissik, and Mittler (2006) describe a 
series of quality collaborative work groups that were sponsored by Center for Health 
Care Strategies (CHCS) and focused specifically on improvements in Medicaid managed 
care enrollees.  Gold et al. (2006) note that these collaboratives provide an opportunity 
for health plans to share ideas with other Medicaid plans and to increase the rigor and 
overall approach to quality improvement activities.  The shared and collaborative focus 
allows plans to learn from each other, while also providing external accountability for 
maintaining focus that might otherwise be absent when the activity remains internal to 
the plan itself.   
While specific outcome data was not reported, the authors indicated that over 
74% of the plans participating in an ongoing collaborative workgroup reported making 
sustained changes to their programs, compared with only 53% of those that participated 
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in single session groups.  The authors suggest that a critical area for improvement lies in 
the ability of plans to measure performance and in the development of standard measures 
and goals to allow better tracking of progress.  One of the benefits of the collaboration 
was that several managed care plans used the workgroups as impetus to work with their 
states Medicaid agencies on barriers to improvement that were external to the health plan 
itself.   
While there have been few detailed studies in this area, other authors have 
suggested that addressing and improving health care across a state is too large a task for a 
single state agency or individual MCO to have significant impact.  They argue for the 
importance of collaboratives that involve multiple stakeholders from the state Medicaid 
agency, MCOs, providers, and others (Krissik, Ireys, Markus, & Rosenbaum, 2008).   
Value Based Purchasing 
In recent years there has been increasing interest and activity directed at aligning 
provider compensation with the quality of care provided.  In 2001, the Institute of 
Medicine, in its report Crossing the Quality Chasm focused attention on serious problems 
with the quality of medical care, and the need to align payment policies with quality 
improvement (Institute of Medicine, 2001).  CMS has also endorsed value based 
purchasing, noting that current systems are based on rewarding the quantity, rather than 
the quality of care.  To achieve a vision of providing “the right care for every person, 
every time”, CMS is shifting to a payment strategy for Medicare services that links the 
amount of payment to the quality of care provided (CMS Hospital Pay for Performance 
Work Group, 2007).  Similarly, more state Medicaid agencies are employing pay for 
performance strategies, as incentives for MCOs, or for health care providers.  
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In an evaluation of pay for performance programs in five Medicaid health plans,  
Felt-Lisk, Gimm, and Peterson (2007) found that while pay for performance was 
effective in improving the timeliness of well baby care, that the effectiveness varied by 
health plan.  Based on their analysis of these programs they concluded that the more 
successful health plans had more effective financial incentives, both in terms of amount 
of the incentive, as well as providing incremental incentives for modest improvements.  
They suggested that good communication between health plans and providers was 
important, along with the provision of technical support to providers (such as providing 
lists of children due for well-baby visits).  
While the importance of Medicaid agencies basing MCO payments on 
improvements in quality has been emphasized (Fossett et al., 2000), there have not been 
any systematic evaluations as to the effectiveness of pay-for-performance at this level.   
External Quality Review Organizations (EQRO) 
Based on requirements outlined in the Balanced Budget Act (BBA), ("Balanced 
Budget Act of 1997,")CMS began requiring states that contract with managed care 
organizations develop a written strategy to monitor and assess the quality of care 
provided to Medicaid recipients.  CMS requires that the states specify the specific goals 
and objectives that will be measured and the overall strategy for how these objectives will 
be achieved.  The state also must require that each MCO have an ongoing quality 
assessment and performance improvement program that conducts performance 
improvement projects; measures performance data; has mechanisms to detect over and 
under utilization of services; and has mechanisms to assess the quality and 
appropriateness of the care furnished to those with special health care needs (Centers for 
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Medicare & Medicaid Services, 2002b).  Additionally, under these requirements state 
Medicaid agencies must contract with an External Quality Review Organization (EQRO) 
to validate performance measures, performance improvement activities, and assess MCO 
compliance with state contracts and federal regulations (Centers for Medicare & 
Medicaid Services, 2003).  In addition, Medicaid agencies can utilize EQROs to conduct 
“optional activities” such as focused studies, providing technical assistance related to 
improvement in a specific area, and producing annual reports on their evaluations. To 
qualify as an EQRO, an organization must at minimum meet the following requirements: 
• Competence: The EQRO must have staff with experience and knowledge 
of Medicaid recipients, policies, processes; managed care delivery 
systems; quality assessment and improvement methods; research design; 
the physical, technical and financial resources to conduct EQR activities, 
and competence to oversee the work of subcontractors. 
• Independence: The EQRO must be independent from the State Medicaid 
Agency and the MCOs that they are reviewing.  They cannot exert control, 
or have any contractual relationships with the MCOs, nor can they deliver 
any health care services to Medicaid recipients.  
A recent study suggested that many states are not aware of or are not fully 
utilizing EQROs to assist in the evaluation and improvement of the delivery of 
developmental services to children (Ireys, Krissik, Verdier, & Melissa, 2005).  Although 
a majority of members enrolled in Medicaid managed care plans are children, the authors 
found that in any given year, few states utilized their contracted EQRO to evaluate the 
quality of preventive or developmental services for children.  When studies were done, 
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they generally calculated the rate or occurrence of EPSDT or well child visits, rather than 
the content of these visits and whether or not preventive services or anticipatory guidance 
are offered.   
Among their recommendations, Ireys et al. (2005) suggest that it is important for 
states to include standards for preventive and developmental services in their quality 
strategy and managed care contracts and to incorporate requirements for improvement in 
preventive or developmental services into mandatory performance improvement projects.  
In addition, they suggest that it will be difficult for a single state agency to make progress 
on improving the state wide provision of preventive or developmental services.  
Therefore they recommend that states develop models and contractual requirements for 
collaboration of multiple stakeholders, including the MCO and EQRO participants (Ireys 
et al., 2005; Krissik et al., 2008).  To be effective, such collaborative arrangements 
should include other stakeholders, such as providers, members, public health 
departments, and others involved in the provision of these services.   
Noting studies that have found associations between the use of electronic medical 
records (EMR) and improved quality of care, the authors suggest that a further avenue to 
pursue is encouraging the adoption of EMR.  This can assist in both documenting the 
provision of developmental services, as well as providing cues or reminders for providers 
as to the services that are due for a particular patient (Krissik et al., 2008). 
Accreditation 
An area not often discussed in the policy literature is establishing requirements for 
accreditation to allow managed care organizations to participate in state Medicaid 
programs.  Accreditation by private organizations can provide independent attestation of 
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a health plan’s adherence to specific quality standards.  In addition, to avoid duplication 
of activities federal regulations allow states to use information obtained from reviews by 
a Medicare or private accrediting organizations to demonstrate compliance with 
requirements for quality oversight of managed care plans (Centers for Medicare & 
Medicaid Services, 2003).    States must specify in their quality strategy those specific 
standards for which they will use the results of the private accreditation review to assess 
compliance, and why these standards are duplicative with the federal and state standards.  
The National Committee for Quality Assurance (NCQA) has developed a 
crosswalk between its standards and federal Medicaid managed care requirements which 
can be used by states as a guide to determining which review activities can be 
streamlined by deeming them as equivalent to NCQA standards.  According to the 
NCQA, 25 states currently use NCQA accreditation, either as a requirement to participate 
in their Medicaid program, or to assist in their external quality review by deeming NCQA 
standards as equivalent to specific federal and state standards (Thurston Toppe & Love, 
2009).   
Summary of Recommendations for State Oversight 
Policy experts have suggested a number of steps that Medicaid agencies can take 
to bolster their efforts to improve access and quality of care for Medicaid recipients 
receiving services through managed health care organizations.  These recommendations 
have focused on leveraging requirements from the BBA and the use of EQROs to 
utilizing standard performance measures such as HEDIS and CAHPS and tying these to 
value based purchasing strategies.  Additional recommendations have focused on 
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beginning to build in plans to use EMR as part of quality improvement strategies and to 
utilize health collaboratives to address statewide improvements.   
While some studies have looked at the evolution of Medicaid quality programs 
over time (Landon & Epstein, 1999; Landon et al., 2004; Landon et al., 1998), there have 
not been any recent studies that have evaluated the extent to which Medicaid agencies 
have implemented a number of these different strategies and whether or not it is possible 
to correlate these strategies with the ability to assess quality outcomes.  
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III. METHODS AND PROCEDURES 
The present study utilized a standardized survey to query state Medicaid agencies 
regarding their quality strategies, and the requirements related to quality improvement 
that they have established for their managed care organizations.  It assessed the degree to 
which Medicaid agencies have adopted recommendations geared toward improving 
quality by evaluating the extent to which state programs have: 
1. Established performance measures based on national or standardized measures; 
2. Implemented a process to report measures and other quality data publicly; 
3. Targeted the reporting of public information toward different stakeholder groups: 
a. Members; 
b. Providers; 
c. Legislators and other regulators; 
d. Advocates; 
4. Encouraged, required or utilized computerized health data; 
5. Established value-based purchasing utilizing some form of reward for high 
performing providers or health plans; 
6. Established a regular process to coordinate multi-stakeholder collaboration 
regarding quality improvement initiatives; 
7. Established a process to evaluate the content and not just the rate of 
developmental services; and 
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8. Incorporated requirements for improvement in developmental and preventive 
services into either their quality strategy, state plan, or MCO contracts 
The study also considered whether there were specific measures being utilized by 
a majority of Medicaid agencies which would allow national reporting of comparative 
quality data.   
Survey Instrument 
A seventy-six item tool was developed to survey Medicaid agency staff on 
various quality measures and strategies that they have adopted as part of their managed 
care programs (Appendix A).  In an effort to increase response rates, the survey was 
designed to allow for quick and efficient input by the respondent.  To increase the 
standardization of the responses, the majority of questions were designed to require 
structured input, such as endorsing the specific quality improvement tools that were used 
by the agency.   The survey was designed as a web-based tool that required user to follow 
a link from an e-mail and select their responses by clicking their mouse.  The tool utilized 
skip logic such that a “No” response preceding a block of questions (such as “Does your 
state require reporting of HEDIS measures?”) would skip all subsequent questions related 
to that response.   The purpose was to focus respondents’ time and attention on only those 
areas relevant to their state and to minimize the response time to complete the survey.  
Pre-testing of the tool using staff members from the Georgia Department of Community 
Health indicated a time of approximately 15 minutes to answer all of the questions.   
The survey instrument was administered through PsychDataTM 
(www.psychdata.com), an internet based survey tool that has been developed specifically 
for social sciences research.  PsychDataTM was chosen because it is specifically designed 
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for academic research and has a number of safeguards to ensure the security and 
confidentiality of data, including encrypted data transmission, password protected data, 
and a secure survey environment which does not store any session data on the user’s 
computer.  In addition, PsychDataTM allows direct export of data into SPSS, which 
streamlined the process of creating the data file for analysis.   
The survey instrument was divided into sections that asked respondents questions 
on: 
• Their managed care program and populations that were covered; 
• Oversight of EPSDT services; 
• Requirements for Performance Improvement Projects; 
• The types of Performance Measures required, and ways that they were used to 
assess quality; and 
• Initiatives focused on Public Reporting, Value Based Purchasing, and 
Electronic Health Data.  
The investigators considered asking more detailed questions regarding the dates 
that specific quality initiatives were started and stopped, along with trended performance 
data or HEDIS data.  While this would have potentially allowed for an assessment of 
which specific quality initiative were associated with specific improvements in quality, 
this information was not requested as part of this study.  It was felt that the level of detail 
required to respond would have discouraged Medicaid staff from participating.  Further, 
it was unlikely that an adequate sample size would have been generated to have sufficient 
statistical power to draw definitive conclusions.  Although quantitative data on 
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improvement was not collected, a subjective assessment was taken by asking respondents 
to indicate whether or not any improvement had occurred on specific performance 
measures over the past three years.   
Survey Distribution 
A list of the Medicaid Directors for all 50 states was compiled from a membership 
listing of the National Association of State Medicaid Directors (NASMD).  A cover letter 
describing the purpose of the study and requesting participation was sent by e-mail to the 
Medicaid Directors of all 50 states by the Quality Director of the Georgia Department of 
Community Health (Appendix B).  The e-mailed letter contained a direct link to the 
survey instrument.  Directors were asked to have the staff member most familiar with the 
managed care quality program complete the survey.  We received five automated 
responses that the original e-mail was not received, either because of an invalid address, 
or because the Medicaid Director for that state had retired.  In each of these cases, the 
correct contact address was identified, either through a search of the agency website or by 
a phone call to the agency, and the e-mailed letter was successfully delivered.  
States that did not respond within two weeks were sent a reminder message by the 
study investigator requesting that they complete the survey within the next week.   A 
third reminder was sent to states that had still not responded after the end of the third 
week.   
A few states requested that a hard copy of the survey questions be sent to them so 
that they could distribute the questions to different content experts, compile the 
responses, and then submit their answers to the on-line survey tool.  A print copy of the 
survey questions was e-mailed to those states that requested it.  
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Data Analysis 
Survey data was downloaded into SPSS for analysis.  Data was analyzed for only 
those Medicaid agencies that reported that they had risk-based managed care programs. 
The analysis included descriptive data as to the number and percentage of state Medicaid 
agencies utilizing each of the different measures and strategies described above.   
A number of the survey questions allowed respondents to select multiple 
responses. For example, the question “Which populations are included in your risk based 
managed care program?” allowed respondents to as few or as many of the listed 
populations that applied.  For these questions a multiple response analysis was used 
which calculated the percentage of all possible responses for each question.  In a single 
response question which allows respondents to select only one answer, the number of 
responses will not exceed the number of respondents.  Thus, 50 states responding to a 
question with four possible choices would yield up to 50 responses.  In a multiple 
response question, 50 states responding to a question with four possible choices could 
yield up to 200 responses (each of 50 states selecting all four choices).  The multiple 
response analysis used in this study produced two statistics, Percent and Percent of 
Cases. Percent reflects the percentage a response is selected relative to the total number 
of responses; the cumulative Percent should not exceed 100.  The Percent of Cases 
reflects the percentage of respondents (States) that selected a particular response; the 
cumulative Percent of Cases can exceed 100 since each state can select more than one 
response.   In this study Percent of Cases was the statistic of interest as the study 
objective was to assess the percentage of states that are using specific quality tools and 
measures.  Therefore the Percent of responses is not displayed in the results tables.  
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In addition to descriptive data, a crosstabs analysis was conducted to assess the 
relationship between the use of pay for performance incentives, performance 
improvement projects and self-reported improvements in quality.   The survey asked 
states that used HEDIS measures as performance measures to indicate 1) which of 35 
HEDIS measures were reported to the state, and of these, which ones 2) were the focus of 
a P4P incentive, 3) were the focus of a PIP, and 4) demonstrated improvement over the 
past three years.  There were 21 states that responded to this section of the survey, and 35 
HEDIS measures.  This resulted in a potential of 735 observations for each of the four 
variables listed above.  Because a state would only be able to know if improvement had 
occurred if the specific measure was reported, the analysis only included HEDIS 
measures that the state indicated were being reported to them.  This resulted in a total of 
329 observations for the variables 1) Focus of P4P incentive; 2) Focus of PIP; and 3) was 
improvement demonstrated.  To determine whether either P4P incentives or PIPs were 
associated with improvements in quality, a crosstab analysis was computed between each 
variable and the variable Improvement demonstrated.  
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IV. RESULTS 
A total of 31 states responded to the survey; of these, 24 (77%) reported that they 
currently had contracts with risk-based managed care programs for their Medicaid 
recipients; 7 (23%) indicated that they had no risk-based managed care contracts.   Of the 
24 states reporting that they had managed care programs, one did not respond to any 
additional questions, thus there were 23 valid responses from state Medicaid agencies 
with risk based managed care programs.  A 2008 report on managed care in Medicaid by 
the Office of the Inspector General (Office of the Inspector General, 2008) identified 37 
states with risk based managed care programs.  Thus the responses for this study reflect 
62% of the states with risk based managed care programs.  
The states responding indicated that they had managed care programs in place for 
an average of 16.30 years, with a range of 3 years to 37 years.  Eighty-two percent (82%) 
reported that their managed care programs had been in effect for 10 or more years.   
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Table 1 – Implementation of Managed Care Program 
 
Using a multiple-response format (meaning that respondents could endorse a 
single or multiple selections), states were asked to report on which populations were 
enrolled in managed care programs.  All of the states indicated that their programs 
included low income children and pregnant women.  In addition, 78% reported that they 
included their SSI populations and 61% reported that they included their medically needy 
populations and members that were in foster care.  Less than 40% reported including 
members covered because they were eligible for both Medicaid and Medicare, or because 
they had breast or cervical cancer. 
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Table 2 – Managed Care Populations 
  N Percent of Cases 
Low income children 23 100.0% 
Pregnant women 23 100.0% 
Medically needy 14 60.9% 
SSI 18 78.3% 
Dual eligible 9 39.1% 
Breast and Cervical Cancer 9 39.1% 
Foster Care 14 60.9% 
Managed Care Populations 
Other (Please specify) 5 21.7% 
 
Although public health providers have traditionally served as safety net providers 
for low-income, uninsured, and Medicaid patients, 32% of the states reported that public 
health providers were not covered by their MCOs.  The states were approximately evenly 
divided on their report as to whether their quality programs has oversight over only their 
managed care programs (48%), or over both their managed care and their fee-for-service 
programs (52%).  
Performance Improvement Projects 
Performance Improvement Projects (PIPs) are required by the BBA and are one of 
the methods policy experts recommend that states use to emphasize improvements in 
quality.  While Medicaid agencies may allow each of their contracted MCOs to choose 
PIPs that they believe are relevant for their membership, one of the ways that states can 
direct efforts to improve quality is to specify specific areas that PIPs should address.   
The number of reported PIPs required by states varied from one to eight, with an 
average of 2.32 per state.  Eighty-one percent of the states require three or fewer PIPs, 
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and there was only one state that required more than four.  A total of 19 of 22 states 
(86%) stated that they specify specific areas that their MCOs must address with their 
PIPs.  As shown in Table 3, the most frequently addressed area was childhood 
immunizations (58%), followed by well child visits (47%), and child chronic conditions 
(32%).  Few states required PIPs to focus on dental services (21%), or access to care 
(21%).  Two states (9%) required PIPs focused on childhood obesity, and only one 
reported  requirements to address prenatal care.  
Some researchers have suggested that utilizing collaborative improvement 
projects, in which various payers, providers, etc. coordinate together to improve care, can 
be more effective that having each MCO embark on their own improvement project.  
Sixteen of 23 states (70%) reported that they require that their MCO conduct one or more 
PIPs in collaboration with other organizations.   Well-child visits were most often the 
focus of a collaborative PIP, required by five states (31%).  This was followed by child 
immunizations (25%), adult chronic conditions (25%), and child chronic conditions 
(19%) (see Table 4).  In most cases the oversight and coordination of the collaborative 
PIP has been conducted by state Medicaid agency staff (87% of states) (see Table 5).   
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Table 3 – Required Performance Improvement Projects 
  N Percent of Cases 
Well Child Visits 9 47.4% 
Immunizations 11 57.9% 
Dental services 4 21.1% 
Child chronic conditions 6 31.6% 
Adult chronic conditions 2 10.5% 
Access to care 4 21.1% 
Member or provider 
satisfaction 
3 15.8% 
Required PIP Areas 
Other (Please specify) 13 68.4% 
 
Table 4 - Focus of Collaborative PIP 
Focus of Collaborative PIP – Multiple Response Frequencies 
  N Percent of Cases 
Well Child Visits 5 31.3% 
Immunizations 4 25.0% 
Dental services 2 12.5% 
Child chronic conditions 3 18.8% 
Adult chronic conditions 4 25.0% 
Access to care 2 12.5% 
Member or provider 
satisfaction 
1 6.3% 
Collaborative PIPs 
Other (Please specify) 8 50.0% 
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Table 5 - Coordination of Collaborative PIP 
  N Percent of Cases 
Medicaid staff 14 87.5% 
EQRO vendor 5 31.3% 
Academic Institution 1 6.3% 
Who Coordinates 
Collaborative PIP 
Other (Please specify) 5 31.3% 
   
 
Incentives and Penalties 
One method for states to encourage achieving specific quality goals is to align 
financial incentives such that MCOs or provider are either rewarded for reaching these 
goals, or penalized for failing to meet established goals.  These may be monetary, in the 
form of additional or higher payments, or may take some other form that is beneficial for 
the MCO or provider.  Only 14 states (61%) reported that they currently provide any 
incentives or penalties that are specifically tied to quality goals; 13 of these states 
specified the types of incentives they provided.   The most common incentive provided 
was a direct financial incentive to an MCO (85%), followed by public recognition for the 
MCO (54%) and preferential auto-assignment of new members to an MCO (46%).   State 
reported that they were less likely to assess penalties or sanctions for failure to meet 
quality goals, with 12 states (55%) reporting that they did so.  Similar to incentives, the 
most common penalty was monetary (67%), followed by loss of assignment of new 
members (50%).   
Of the 13 states that reported specific quality incentives, only two states (15%) 
reported making direct incentive payments to providers.  These two states, plus two 
additional, reported that they required their MCOs to provide quality incentives to 
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providers, while a total of 15 states (68%) reported that their MCOs were voluntarily 
providing some form of quality incentives directly to providers.  The type of provider 
most likely to receive some form of incentive payment was a small primary care practice 
(71% of states), followed by large outpatient groups (57%), and public health clinics 
(36%).   
 
Table 6 - Provider Incentives 
  
N 
Percent of 
Cases 
If yes, what provider groups are eligible to 
participate in the pay for performance 
program?: Hospitals 
3 21.4% 
Large outpatient groups (IPAs, PHOs, etc) 8 57.1% 
Small or individual primary care practices 10 71.4% 
Public health clinics 5 35.7% 
Provider Incentives 
Other (Please specify) 3 21.4% 
   
 
Performance Measures 
All of the states responding reported that they relied on the use of some type of 
standardized performance measures to evaluate the quality of care and service delivered 
to their members.  Of these, 96% reported that they utilized HEDIS measures; the one 
state that was not using HEDIS measures indicated that they were using “HEDIS-like” 
measures.  In addition to HEDIS measures a few states also reported using measures that 
have been developed by CMS (17%) and the Agency for Healthcare Research and 
Quality (AHRQ) (13%); two states reported the use of local, state-developed performance 
measures (see Table 7).  
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Table 7 – Use of Standardized Performance Measures 
Standard Performance Measures - Multiple Response Frequencies 
  N Percent of Cases 
HEDIS 22 95.7% 
CMS 4 17.4% 
AHRQ 3 13.0% 
Standard Performance 
Measures
a
 
Other (Please specify) 9 39.1% 
 
All but two states (91%) reported that they relied on non-standardized 
performance measures to assess the quality of their programs.  They indicated that these 
measures were used most frequently to measure access to care (78%), followed by 
utilization of services (70%) and provider networks (52%) (Table 8).   
 
Table 8 – Use of Non-standard Performance Measures 
  N Percent of Cases 
Provider networks 12 52.2% 
Access to care 18 78.3% 
Processes of care 9 39.1% 
Health outcomes 9 39.1% 
Utilization of service 16 69.6% 
Do not use any non-standard 
performance measures 
2 8.7% 
Non Standard Performance 
Measures 
Other (Please specify) 6 26.1% 
 
HEDIS Measures 
One of the most consistently reported means of evaluating quality by the different 
states was the use of HEDIS measures, with 96% reporting their use.  States were asked 
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to indicate which of 35 HEDIS measures were 1) reported to the state; 2) the focus of a 
pay-for-performance incentive; 3) the focus of a performance improvement project; and 
4) whether any improvement had been demonstrated on this measure over the past three 
years.  
The measures most frequently utilized by states for assessing quality are 
presented in Table 9.   Given that all states responding reported including low income 
children in their managed care populations, it is not surprising that the most frequently 
used measures pertained to services delivered to, or relating to the health of children.  
These included well visits for children and for adolescents, prenatal and postpartum care, 
and childhood immunization status.  Other frequently used measures that may relate to 
children or adults included measures of appropriate medications for people with asthma, 
comprehensive diabetes care, and member satisfaction.   Although there has been much 
recent concern related to the provision of dental services for Medicaid children (Centers 
for Medicare & Medicaid Services, 2009), only 50% of the states reported using the 
HEDIS measure Annual Dental Visit.  A recent policy brief suggested that when 
compared with privately insured children, children covered by Medicaid are more likely 
to have untreated tooth decay and to be in need of urgent dental care.  It also noted that 
parents of publicly insured children identified dental care as the greatest unmet medical 
need (Paradise, 2009).   
 Measures reflecting the quality of mental health services were not generally 
reported, with only 30% of states indicating they report on a measure of follow-up after a 
mental health hospitalization, and only 10% stating that they measure the follow-up care 
for children prescribed ADHD medications.   
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Table 9 – HEDIS Measures Reported to the State 
    
  
N 
Percent of 
Cases 
Well-Child Visits in the 
Third, Fourth, Fifth and 
Sixth Years of Life 
20 100.0% 
Well-Child Visits in the First 
15 Months of Life 
20 100.0% 
Use of Appropriate 
Medications for People With 
Asthma 
19 95.0% 
Adolescent Well-Care Visits 18 90.0% 
CAHPS Health Plan Survey 
4.0H, Adult Version 
18 90.0% 
Prenatal and Postpartum 
Care 
17 85.0% 
Childhood Immunization 
Status 
16 80.0% 
Comprehensive Diabetes 
Care 
16 80.0% 
CAHPS Health Plan Survey 
3.0H, Child Version 
16 80.0% 
Cervical Cancer Screening 13 65.0% 
Breast Cancer Screening 13 65.0% 
Children's and Adolescents' 
Access to Primary Care 
Practitioners 
12 60.0% 
Adults' Access to 
Preventive/Ambulatory 
Health Services 
11 55.0% 
Frequency of Ongoing 
Prenatal Care 
10 50.0% 
Annual Dental Visit 10 50.0% 
Lead Screening in Children 9 45.0% 
Controlling High Blood 
Pressure 
8 40.0% 
Cholesterol Management 
for Patients With 
Cardiovascular Conditions 
8 40.0% 
Chlamydia Screening in 
Women 
8 40.0% 
Appropriate Testing for 
Children With Pharyngitis 
8 40.0% 
Appropriate Treatment for 
Children With Upper 
Respiratory Infection 
8 40.0% 
Children With Chronic 
Conditions 
8 40.0% 
Follow-Up After 
Hospitalization for Mental 
Illness 
6 30.0% 
Medical Assistance With 
Smoking Cessation 
6 30.0% 
Antidepressant Medication 
Management 
5 25.0% 
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N 
Percent of 
Cases 
Annual Monitoring for 
Patients on Persistent 
Medications 
4 20.0% 
Avoidance of Antibiotic 
Treatment in Adults With 
Acute Bronchitis 
4 20.0% 
Beta-Blocker Treatment 
After a Heart Attack 
4 20.0% 
Persistence of Beta-Blocker 
Treatment After a Heart 
Attack 
3 15.0% 
Use of Imaging Studies for 
Low Back Pain 
3 15.0% 
Disease Modifying Anti-
Rheumatic Drug Therapy 
for Rheumatoid Arthritis 
2 10.0% 
Follow-Up Care for Children 
Prescribed ADHD 
Medication 
2 10.0% 
Use of Spirometry Testing 
in the Assessment and 
Diagnosis of COPD 
2 10.0% 
Pharmacotherapy of COPD 
Exacerbation 
1 5.0% 
Initiation and Engagement 
of Alcohol and Other Drug 
Dependence Treatment 
1 0 
 
With regard to efforts to improve quality as reflected by these measures, 
Childhood Immunization Status was the measure that was most frequently the focus of a 
pay for performance incentive (82%), and most frequently reported to be included in a 
performance improvement project (60%), as well as the measure most frequently cited as 
having shown improvement (92%).  Of 21 states that reported that they utilized HEDIS 
measures to assess quality of care,  20 states (95%) reported that they had HEDIS 
measures reported to them by their MCOs, 15 (71%) indicated that they were the focus of 
a PIP, and only 11 (52%) reported that they were utilizing them as part of a pay for 
performance incentive. Thirteen states (62%) reported that they had observed some 
improvement on theses measures over the past three years (Table 11).    
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Table 10 – Use of HEDIS Measures for Quality Improvement  
          
  Report HEDIS 
  
    
Frequency 
Valid 
Percent 
HEDIS Measure 
Reported to State 
Yes 20 95.2 
  No 1 4.8 
  
Valid 
Total 21 100.0 
  Missing System 2   
  
Total 23   
          
  HEDIS PIP 
  
    
Frequency 
Valid 
Percent 
Focus of PIP Yes 15 71.4 
  No 6 28.6 
  
Valid 
Total 21 100.0 
  Missing System 2   
  
Total 23   
          
  HEDIS P4P 
  
    
Frequency 
Valid 
Percent 
Focus of P4P Yes 11 52.4 
  No 10 47.6 
  
Valid 
Total 21 100.0 
  Missing System 2   
  
Total 23   
          
  HEDIS Improvement 
  
    
Frequency 
Valid 
Percent 
Reported Improvement Yes 13 61.9 
  No 8 38.1 
  
Valid 
Total 21 100.0 
  Missing System 2   
  Total 23   
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Table 11 – HEDIS Measures – Strategies for Improvement 
  P4P   PIP   Improvement 
  
N 
Percent of 
Cases N 
Percent of 
Cases N 
Percent of 
Cases 
Childhood Immunization 
Status 
9 81.8% 9 60.0% 12 92.3% 
Adolescent Well-Care Visits 7 63.6% 6 40.0% 9 69.2% 
Well-Child Visits in the 
Third, Fourth, Fifth and 
Sixth Years of Life 
6 54.5% 4 26.7% 10 76.9% 
Use of Appropriate 
Medications for People With 
Asthma 
6 54.5% 6 40.0% 9 69.2% 
Prenatal and Postpartum 
Care 
6 54.5% 2 13.3% 9 69.2% 
Comprehensive Diabetes 
Care 
6 54.5% 4 26.7% 8 61.5% 
Cervical Cancer Screening 6 54.5% 1 6.7% 5 38.5% 
Lead Screening in Children 6 54.5% 3 20.0% 7 53.8% 
Well-Child Visits in the First 
15 Months of Life 
5 45.5% 3 20.0% 11 84.6% 
Frequency of Ongoing 
Prenatal Care 
4 36.4% 1 6.7% 5 38.5% 
Controlling High Blood 
Pressure 
4 36.4% 
 
  2 15.4% 
CAHPS Health Plan Survey 
4.0H, Adult Version 
3 27.3% 1 6.7% 4 30.8% 
Breast Cancer Screening 3 27.3% 1 6.7% 4 30.8% 
Children's and Adolescents' 
Access to Primary Care 
Practitioners 
3 27.3% 2 13.3% 7 53.8% 
Annual Dental Visit 3 27.3% 3 20.0% 5 38.5% 
Cholesterol Management 
for Patients With 
Cardiovascular Conditions 
3 27.3% 
 
  3 23.1% 
CAHPS Health Plan Survey 
3.0H, Child Version 
2 18.2% 1 6.7% 4 30.8% 
Adults' Access to 
Preventive/Ambulatory 
Health Services 
2 18.2% 1 6.7% 4 30.8% 
Chlamydia Screening in 
Women 
2 18.2% 
  
  2 15.4% 
Follow-Up After 
Hospitalization for Mental 
Illness 
2 18.2% 
 
  1 7.7% 
Appropriate Testing for 
Children With Pharyngitis 
1 9.1% 
 
  3 23.1% 
Appropriate Treatment for 
Children With Upper 
Respiratory Infection 
1 9.1% 1 6.7% 4 30.8% 
Children With Chronic 
Conditions 
1 9.1% 1 6.7% 3 23.1% 
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  P4P   PIP   Improvement 
  
N 
Percent of 
Cases N 
Percent of 
Cases N 
Percent of 
Cases 
Medical Assistance With 
Smoking Cessation 
1 9.1% 
  
  1 7.7% 
Antidepressant Medication 
Management 
1 9.1% 
  
  
  
  
Annual Monitoring for 
Patients on Persistent 
Medications 
1 9.1% 
 
  1 7.7% 
Persistence of Beta-Blocker 
Treatment After a Heart 
Attack 
1 9.1% 
  
  
  
  
Use of Imaging Studies for 
Low Back Pain 
1 9.1% 
  
  1 7.7% 
Disease Modifying Anti-
Rheumatic Drug Therapy 
for Rheumatoid Arthritis 
1 9.1% 
  
  1 7.7% 
Follow-Up Care for Children 
Prescribed ADHD 
Medication 
1 9.1% 1 6.7% 1 7.7% 
Avoidance of Antibiotic 
Treatment in Adults With 
Acute Bronchitis 
  
  
  
  
  
  
Beta-Blocker Treatment 
After a Heart Attack   
  
  
  
  
  
Use of Spirometry Testing 
in the Assessment and 
Diagnosis of COPD   
  1 6.7% 1 7.7% 
Pharmacotherapy of COPD 
Exacerbation   
  
  
  
  
  
Initiation and Engagement 
of Alcohol and Other Drug 
Dependence Treatment 
        1 0 
Totals 98   52   138   
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Table 12 – Number of HEDIS Measures Reported to Medicaid Agencies 
No. of HEDIS Measures 
 
Number of 
Measures 
Reported 
Number of 
States 
Frequency Percent Valid Percent 
Cumulative 
Percent 
.00 1 4.3 4.8 4.8 
7.00 1 4.3 4.8 9.5 
9.00 1 4.3 4.8 14.3 
11.00 2 8.7 9.5 23.8 
12.00 1 4.3 4.8 28.6 
13.00 2 8.7 9.5 38.1 
14.00 2 8.7 9.5 47.6 
15.00 1 4.3 4.8 52.4 
16.00 2 8.7 9.5 61.9 
18.00 1 4.3 4.8 66.7 
19.00 1 4.3 4.8 71.4 
20.00 2 8.7 9.5 81.0 
21.00 2 8.7 9.5 90.5 
29.00 1 4.3 4.8 95.2 
30.00 1 4.3 4.8 100.0 
Valid 
Total 21 91.3 100.0  
Missing 
System 2 8.7   
Total 23 100.0   
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Table 13 – Number of Pay for Performance Incentives 
Number of P4P Incentives 
 
Number of 
P4P 
Incentives 
Number of 
States 
Frequency Percent Valid Percent 
Cumulative 
Percent 
.00 10 43.5 47.6 47.6 
1.00 1 4.3 4.8 52.4 
3.00 1 4.3 4.8 57.1 
4.00 2 8.7 9.5 66.7 
5.00 1 4.3 4.8 71.4 
6.00 1 4.3 4.8 76.2 
8.00 1 4.3 4.8 81.0 
11.00 1 4.3 4.8 85.7 
15.00 1 4.3 4.8 90.5 
17.00 1 4.3 4.8 95.2 
24.00 1 4.3 4.8 100.0 
Valid 
Total 21 91.3 100.0  
Missing System 2 8.7   
Total 23 100.0   
 
 
Table 14 – Number of Performance Improvement Projects 
Number of PIPs 
 
Number of 
PIPs 
Number of 
States 
Frequency Percent Valid Percent 
Cumulative 
Percent 
.00 6 23.1 28.6 28.6 
1.00 4 17.4 19.0 47.6 
2.00 1 4.3 4.8 52.4 
3.00 3 13.0 14.3 66.7 
4.00 2 8.7 9.5 76.2 
5.00 3 13.0 14.3 90.5 
6.00 1 4.3 4.8 95.2 
8.00 1 4.3 4.8 100.0 
Valid 
Total 21 91.3 100.0  
Missing System 2 8.7   
Total 23 100.0   
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To assess the degree to which PIPs or P4P incentives may be related to reported 
improvement in HEDIS measures, a crosstabs analysis was computed combining data 
from all 21 states that responded to this set of questions and all 35 HEDIS measures.  
This resulted in 735 potential observations for each of the three variables: whether a PIP 
was conducted; whether a P4P incentive was in place; and whether any improvement was 
reported by the state Medicaid agency.  Eliminating observations for HEDIS measures 
that were not reported to the state resulted in a total of 329 observations.  When no P4P 
incentive was in place, improvement was demonstrated in only 31.4% of the cases, as 
opposed to 68.8% of the cases when a P4P incentive was in place.  Thus, having a PIP in 
place was significantly associated with a reported improvement in performance Χ2=38.4, 
p<.001 (see Table 15).   
 
Table 15 - Crosstabs: P4P & Improvement 
P4P Incentive *Improvement Demonstrated Crosstabulation 
   Improvement Demonstrated 
   Improvement 
Demonstrated - 
Unchecked 
Improvement 
Demonstrated - 
Checked Total 
Count 162 74 236 P4P Incentive - 
Unchecked 
%  P4P Incentive 68.6% 31.4% 100.0% 
Count 29 64 93 
P4P Incentive 
P4P Incentive - 
Checked 
%  P4P Incentive 31.2% 68.8% 100.0% 
Count 191 138 329 Total 
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Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 38.445
a
 1 .000   
Continuity Correction
b
 36.922 1 .000   
Likelihood Ratio 38.546 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 38.328 1 .000   
N of Valid Cases 329     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 39.01. 
b. Computed only for a 2x2 table 
 
 Similarly a having a PIP was also associated with improved performance.  When 
there was no PIP associated with a HEDIS measure, improved occurred in 37.8% of the 
cases, as opposed to 64.7% of the cases with a PIP.  This association was also significant, 
Χ2=12.8, P<.001 (see Table 16). 
 
Table 16 - Crosstabs: PIP & Improvement 
Focus of PIP *  Improvement Demonstrated Crosstabulation 
    Improvement Demonstrated 
   Improvement 
Demonstrated - 
Unchecked 
Improvement 
Demonstrated - 
Checked Total 
Count 173 105 278 Focus of PIP - Unchecked 
% within PIP  62.2% 37.8% 100.0% 
Count 18 33 51 
Focus of PIP  
Focus of PIP - Checked 
% within PIP  35.3% 64.7% 100.0% 
Count 191 138 329 Total 
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Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 12.840
a
 1 .000   
Continuity Correction
b
 11.758 1 .001   
Likelihood Ratio 12.705 1 .000   
Fisher's Exact Test    .001 .000 
Linear-by-Linear Association 12.801 1 .000   
N of Valid Cases 329     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 21.39. 
b. Computed only for a 2x2 table 
 
Public Reporting 
As noted by Verdier & Hurley (2004), public reporting of quality data can be 
important in providing a level of transparency regarding efforts to improve quality, 
engaging stakeholders by providing data and feedback on the results of quality initiatives, 
and encouraging competition between MCOs and providers to improve performance on 
quality measures. Most states (87%) indicated that they do report at least some of their 
quality data publicly.  The most common method of reporting is this information was 
through an annual report posted on a web-site (85%).  Slightly less than half the states 
reported posting information on a health transparency website (45%) or producing a hard 
copy report (40%).  
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Table 17 - Methods of Public Reporting of Data 
  N Percent of Cases 
Annual Report (web based) 17 85.0% 
Annual Report (paper or hard copy) 8 40.0% 
Transparency or health information 
website 
9 45.0% 
Public Reporting of 
Data 
Other 2 10.0% 
   
 
Although it has been recommended that Medicaid agencies tailor the reporting of 
public data to the specific target audience, only 5 states (25%) indicated that they did this.   
Electronic Health Records 
A significant proportion of states (68%) reported having some initiative to 
increase the use of electronic health records.  Some of these projects were reported to be 
funded through CMS Medicaid transformation grants and others through state grants.  
Initiatives were focused across of range of provider types, including inpatient and 
outpatient.  Some focused specifically on assisting providers in adopting electronic health 
records, while others described initiatives to link providers electronically to a central 
database that tracked the provision of services from claim or prescription data.  Only four 
states reported using any electronic health data to capture quality measures, those that 
did, described obtaining data from immunization registries, or electronically transmitting 
claim data to calculate HEDIS measures.  
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Preventive/Developmental Services (EPSDT) 
With all of the states responding indicating that low-income children were 
included in their managed care programs, assessment of the quality of developmental 
services should be a significant component.  States were asked a variety of questions as to 
how they evaluated the quality of developmental services (or services provided under 
EPSDT regulations).   A majority of states (82%) reported that they did have specific 
provisions regarding the evaluation of developmental services.   Of these, the majority 
indicated that these provisions were specified directly in their managed care contracts 
(89.5%), followed by the state quality strategy (42%), the state plan (32%), and EQRO 
contracts (26%).   
 
Table 18 – Provisions for Evaluation of Developmental Services 
  N Percent of Cases 
State Plan 6 31.6% 
State Quality Strategy 8 42.1% 
MCO Contracts 17 89.5% 
EQRO Contracts 5 26.3% 
Defined Provisions for EPSDT 
Other (Please specify) 3 15.8% 
   
 
States reported that the quality of developmental services is primarily assessed 
through an evaluation of performance measures (84%), while about half also utilize 
medical record reviews (52%) and four states indicated that they assessed services either 
through member surveys or focus groups (21%).  None of the states reported using 
surveys designed specifically for assessing developmental services, such as the 
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Promotion of Healthy Development Survey (PHDS), or the Young Adult Health Care 
Survey (YAHCS).   
 
Table 19 – Methods Used to Assess Developmental Services 
  N Percent of Cases 
Performance Data 16 84.2% 
Medical Record Review 10 52.6% 
Focus groups or surveys of 
members 
4 21.1% 
Assess Developmental Services 
Other (Please specify) 7 36.8% 
   
 
States generally reported relying on Medicaid (74%) or MCO (74%) staff to 
conduct the evaluation of developmental services.  Fewer states reported that they relied 
on their EQRO vendor (42%) to conduct these assessments.  While use of MCO staff to 
evaluate the provision of developmental services generally was coupled with the use of 
Medicaid or EQRO staff reviews, in one state the only method consisted of MCO 
medical record reviews.  
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V. DISCUSSION AND CONCLUSION 
This study sought to evaluate the approaches that state Medicaid agencies are 
taking to monitor and improve the quality of care delivered to recipients covered under 
their managed care programs.  The results of this study indicate that state Medicaid 
agencies have adopted a number of the recommendations that have been made by policy 
researchers and that there has been greater adoption of standard performance measures 
across states.  Public reporting of quality data appears to be increasing, but it does not 
appear that most states specifically target the type of information reported to a specific 
audience. 
A number of policy experts (Corrigan et al., 2002; Ramirez de Arellano & Wolfe, 
2007) have stressed the need for state Medicaid agencies to use standardized measures to 
assess quality, and to  allow comparative assessments of quality across states to occur.  
The findings of this study suggest that this is happening, with all but one of the states 
with managed care programs stating that they utilize HEDIS measures as one of their 
methods to assess quality (the one state reporting that they did not use HEDIS indicated 
that they use HEDIS like measures and are planning to move to standard HEDIS 
measures in the future).  While none of the states reported using all available HEDIS 
measures, there are a number of common measures that are currently being utilized by a 
majority of states.  The measures that were used most consistently were those for 
evaluating the utilization of well visits for both children and adolescents; the use of 
appropriate medications for people with asthma;  the timeliness of prenatal and 
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postpartum care; childhood immunization status; comprehensive diabetes care; and 
member satisfaction surveys of both children and adults.  These measures were used by 
80% or more of the states responding to this survey and are relevant to the population of 
low income children and pregnant women who are included in every state’s managed 
care program.  Over 95% of the Medicaid agencies reported that they would find it 
moderately or extremely useful to have a central site for reporting Medicaid quality 
measures.  The common use of these measures across states would make it relatively easy 
to introduce them as a core set of measures that all state Medicaid agencies would report, 
allowing for the possibility of comparative analysis of different Medicaid programs.   
Additional measures that are relevant (such as use of dental services, or mental health 
measures) could be added to the core set over time.  Other measures that may be relevant 
for specific populations, such as pharmacotherapy for COPD patients, could be 
established as optional measures to be utilized by states targeting those conditions.  
Most Medicaid agencies report using their contracting authority to emphasize 
areas for quality improvement, with 86% indicating that they delineate specific areas that 
must be addressed by PIPs.  The findings from this study suggest that implementing PIPs 
are associated with improvements in performance measures, with improvement noted on 
64.7% of HEDIS measures that were associated with PIPs, as opposed to 37.8% of those 
measures not associated with a PIP.   Additionally, a majority of states (70%) have 
adopted practices that are in line with recommendations  that PIPs be done 
collaboratively (Gold et al., 2006; Ireys et al., 2005; Krissik et al., 2008).  Ireys et al 
(2005) voiced concerns that state agencies alone would find it difficult to drive major 
improvements in quality, and that true improvement would require collaborative efforts 
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by a number of stakeholders, including MCOs, providers, members, and community 
organizations.  Although many states do require collaborative improvement projects, a 
majority are also relying on their own staff to coordinate these activities.  With tightening 
state budgets, a concern is that agency staff may be pulled in multiple directions and find 
that they are not able to devote the resources necessary to keep a collaborative 
improvement project moving.  Ireys et al (2005) suggest that utilizing EQRO contracts to 
oversee collaborative projects may be a more viable alternative, though one that not many 
states appear to be using at the present time.  
Public reporting, value based purchasing, and adoption of health information 
technology have all been receiving much attention as promising strategies to further 
improve the quality of health care.  The data from this study indicate that state Medicaid 
agencies are moving toward utilizing these strategies, though they have not yet adopted 
them as fully as reporting of performance measures and implementation of performance 
improvement projects.  At this point, of the three areas, public reporting of data has been 
most consistently adopted, with 87% of the states responding indicating that they report 
their quality data publicly in some form.   The data suggests that for most states, public 
reporting has taken the form of an annual report that is posted to a web site (in many 
cases this appears to be the EQRO evaluation).  Few states have adopted 
recommendations to report comparative data targeted to the interests and understanding 
of different stakeholders.  While the level of detail in most evaluative reports is helpful to 
health care professionals, it may not address the specific questions that legislators may 
have related to questions such as the cost-effectiveness of programs, or help members 
make determinations as to which health plan they would like to select.  The use of reports 
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and  information that is targeted toward specific stakeholders will be more likely to 
continually drive quality performance toward further improvements, however, it also 
requires more resources to determine the information that different stakeholders want and 
then formatting information differently for their use.   
Value based purchasing (using either incentives or sanctions) has been utilized 
less than public reporting.  Although the Institute of Medicine (2001) has stressed the 
need to align payment strategies with desired improvements in quality, only 61% 
currently report having taken this step.  The strategies of public reporting and pay for 
performance both require the development of valid and reliable performance measures.  
In addition, pay for performance programs may also require the procurement of 
additional funds (which may be difficult for many state agencies).   In fact, a recent 
survey of state Medicaid directors indicated that the current economic conditions were 
leading to cutbacks in Medicaid programs, including P4P incentives (Smith et al., 2009)  
The findings of this study suggest that P4P incentives, as well as PIPs are 
associated with improvements in performance.  States reported improvement on 68.8% of 
HEDIS measures when P4P incentives were utilized, as compared with 31.4% when they 
were not.  While the self-report nature of this study design limits the strength of this 
conclusion, other studies have also suggested positive impact with P4P incentives.     
Felt-Lisk et al (2007) suggest that it is important for incentives to be sufficiently large to 
be perceived as a reward by the target of the incentive (health plans, providers).  They 
also must be carefully designed to assure that they are rewarding the desired behavior and 
minimizing potential unintended consequences, such as having providers or health plans 
avoid sicker patients.  A possible strategy to address this would be to broadening pay for 
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performance incentives from paying to meet a specific performance goal to also 
providing incentives for adopting practices that have been shown to improve general 
health outcomes, such as becoming a patient’s medical home (i.e., rewarding 
improvements in both process and outcomes).  
In addition to providing incentives, 55% of the states reported that they also 
assess penalties for MCOs that fail to meet quality goals.  There is little empirical 
literature examining the differential effect of incentives versus penalties on performance.  
Conrad and Perry (2009) in a review of the literature, found only two studies that 
included both incentives and rewards in their evaluation.  The first study, evaluating a 
CMS P4P program with hospitals was not yet completed.  A second study that found 
significant improvement in diabetes care processes based on a program combining 
incentives and withholds was not designed to differentiate the effects of incentives versus 
penalties.  They suggest that both rewards and penalties have their place in value based 
purchasing, and theorize that penalties may have a greater effect, based on economic 
theory of risk aversion that postulates that individuals assign greater weight to potential 
losses than potential gains (Conrad & Perry, 2009; Weimer & Vining, 2005).  This will 
be an area for further research to evaluate.  
Widespread use of electronic health records (EHR) will allow standard 
performance measures to move beyond data based largely on claim data reflecting the 
occurrence of a service or procedure.  Electronic records will allow for more efficient 
capturing of data that reflects both the treatments that are being used and the clinical 
response to these treatments, allowing a truer picture of whether outcomes are improving 
as a result of quality improvements efforts.  Additionally, the use of EHR also can 
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facilitate actual improvements in quality by providing additional tools for providers (in 
terms of reminders of patient care that is due, alerts related to potential drug interactions, 
and sharing of pertinent medical information between providers to improve care 
coordination), as well as creating more opportunities to engage patients in their own care 
through patient portals.   
Several states are beginning to support providers in adopting electronic health 
records, both through CMS Medicaid transformation grants, as well as state grants.  This 
support will likely accelerate over the next few years with further incentives that are 
provided through the recent American Recovery and Reinvestment Act of 2009 (ARRA) 
("American Recovery and Reinvestment Act of 2009,").  The ARRA provides $17.2 
billion in incentives through Medicaid and Medicare payments, to assist providers in 
adopting EHRs.  This includes incentive payments, beginning in 2011, for providers that 
are able to demonstrate “meaningful use” of certified EHR technology.  While 
“meaningful use” has not been fully defined yet, the provisions describe a meaningful 
user as one who, uses the technology for such clinical tasks as electronic prescribing; 
demonstrates the electronic exchange of information in such a way as to promote care 
coordination; and submits data on clinical quality measures (Healthcare Information and 
Management Society, 2009).   Given the degree to which the population of Medicaid 
beneficiaries lags behind commercially insured patients in many preventive and care 
management measures, it will be important the Medicaid officials advocate for a 
definition of meaningful user that addresses these deficits.  This may include using the 
EHR to facilitate the tracking and delivery of preventive services for individual patients, 
as well as allowing and encouraging physicians to track the delivery of these services for 
60 
their population of patients (such as the percentage of their patients that are up to date 
with their immunizations, or the percentage of asthmatic children maintained on 
appropriate medication).  These elements of a “meaningful user” if realized, should 
support improvements in both the delivery and measurement of quality care.   
Although all states include children in their managed care populations, it appears 
that only a few states have implemented many of the recommendations made by Ireys et 
al (2005) regarding the provision of developmental services.  While most states indicated 
that they have included provisions for improving the quality of developmental services in 
their MCO contracts, state plan, quality strategy, or EQRO contracts, few reported 
actually evaluating the content of developmental screening visits as suggested by Ireys et 
al (2005).  It is likely that one of the major limitations for most states in this regard are 
the resources required to either conduct medical record reviews, or surveys of patients 
regarding the specific services that they have received.  
Of concern is the fact that only 68% of the states indicated that public health 
providers were covered by their managed care organizations.  In addition, of states that 
had P4P incentives, only 36% made them available to public health providers, as opposed 
to 71% that included primary care providers.  Given that public health providers have 
served as a traditional safety net for individuals with low-incomes or no insurance, the 
inability to utilize these providers under Medicaid managed care programs could result in 
disruptions in the continuity of care.  Indeed, several studies have suggested the public 
health providers have fared poorly under a shift to managed care (Boehm, 2005; Louise, 
2005; Willging, Waitzkin, & Nicdao, 2008).  However, a recent survey suggested that 
despite initial difficulties safety net providers encountered with managed care, many had 
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managed to adapt to these changes (Lewin & Baxter, 2007).  This survey suggests that 
further study is required as to how public health providers fare under managed care 
arrangements, as well as changes that may be necessary for them to compete with private 
providers while continuing to serve those patients that are most vulnerable and lack other 
resources to access care. Additionally it will be important to determine the impact that 
public health providers have on access, continuity of care, and quality.  
Limitations 
The current study utilized a structured internet based survey to collect data on 
state Medicaid agencies approaches to quality improvement.  While this had the 
advantage of standardizing the data across all states, it did not allow for the richness of 
data that would have been possible through direct interviews with Medicaid agency staff.  
Additionally the number of questions asked was limited to keep the time required to 
respond low with the goal of increasing the response rate.  The goal was to provide a 
broad view of the approaches that state Medicaid agencies are taking to improve quality. 
However, more detailed nuances as to how different Medicaid agencies implemented 
these strategies, such as collaborative PIPs, or P4P programs, cannot be described.  For 
example, while the data indicated that 70% of state Medicaid agencies require one or 
more collaborative PIPs, this data does not tell us more about the extent or the success of 
the collaboration.  It could be instructive to know who participated in collaborative 
activity (e.g., other MCOs, other state agencies, public health organizations, community 
organizations, providers, etc)., what strategies were successful in recruiting and 
sustaining the engagement of other stakeholders as well as the activity itself, sources of 
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funding activities, and which strategies were associated with improvements in care and 
outcomes.    
This study was prone to several limitations that are common to the use of self-
report survey data.   It is possible that a positive response bias existed, with respondents 
endorsing items that would present their agency in the most positive light.  Although 
most of the questions relied on terminology that is common to the Medicaid program, it is 
possible that the interpretation of some questions may have varied with each respondent, 
thus a collaborative PIP may have meant different things to different states.  The survey 
instructions also requested that responses come from the person “most knowledgeable 
about your Medicaid quality program.”  However, it is possible that this person may not 
have been the content expert for all of the areas evaluated in this study.  In fact, some 
states requested a hard copy of the survey questions so that they could be reviewed and 
answered by several people, each knowledgeable of different areas.  Finally, evaluation 
as to the degree to which different strategies or interventions were actually implemented 
in any of the states was beyond the scope of this study.  However, the range and extent to 
which P4P incentives or performance improvement activities are implemented surely 
varies from one state to another and this variance will impact their effectiveness in 
improving quality.   
Detailed questions regarding performance measures focused primarily on HEDIS 
measures as this is one of the most common measure sets used within managed care 
settings.  However, there are a number of other standard performance measures, such as 
those developed by the National Quality Foundation (NQF), and others, which may be 
utilized by state Medicaid agencies but were not assessed as part of this study.   
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Although respondents were asked about areas where improvements in quality had 
occurred, it was beyond the scope of this study to evaluate whether any of the specific 
strategies described were more effective than others in leading to improvement.  To be 
able to conduct this level of analysis would have required measuring the specific dates 
that different strategies were implemented, and the collection of specific performance 
measures over time.  This would be a separate study, but one that will be important to 
conduct.  As Medicaid agencies cope with shrinking budgets and fewer resources one of 
the crucial questions will be which strategies will be most cost effective in achieving 
improvements in health care quality.   
The study included responses from 23 of 37 states with risk based managed care 
programs.  While the sample included many larger states and many of those with 
longstanding programs, and thus seems representative of the current state of quality 
oversight in Medicaid managed care, a larger sample would have been preferred.  Due to 
a number of factors, the survey was distributed in January, a time when most states are 
beginning their legislative sessions and placing much demand on state agencies.  Thus the 
timing of the survey distribution may have limited the number of responses that were 
received.  
Suggestions for Future Research 
The current study provides a broad overview of the types of activities that state 
Medicaid agencies are doing to assess and improve quality, as well as suggests that some 
of these activities are associated with improvements in care.  It expands on the findings of 
previous research and indicates that state Medicaid agencies are continuing to mature and 
further develop their capacity to evaluate and improve the quality of care received by 
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beneficiaries in their managed care programs.  However, similar to other studies on 
quality improvement activities; this study does not evaluate the comparative effectiveness 
of various strategies and their impact in different environments and across different 
populations.  While a number of articles have stressed the importance of strategies such 
as pay for performance, public reporting, and performance improvement collaboratives, it 
would be useful to evaluate the comparative effectiveness of each of these strategies.  
With continuing pressure on Medicaid agencies to contain, or reduce expenditures, it 
becomes increasingly important to be able to demonstrate the return on investments in 
quality improvement.  Without such data it may be difficult to obtain additional funding 
from state legislatures for initiatives such as P4P programs, even with documentation that 
they can improve quality.  
To date, research on the role of Medicaid agencies in improving the quality of 
care has largely relied on surveys and interviews of Medicaid or MCO staff regarding the 
various initiatives that have been utilized.  With the exception of studies that have 
evaluated the use of P4P incentives, there have been few studies that have empirically 
evaluated the impact of different quality improvement strategies. While the current study 
found an association between P4P incentives and public reporting of data, and reported 
improvement in performance measures, future research should more carefully assess the 
specific components of these interventions that are associated with improvement in 
healthy behaviors and health outcomes of Medicaid recipients. 
Managed Medicaid programs typically have included low-income women and 
children in their population, while leaving many with more significant medical needs, 
such as the elderly, disabled, and medically needy populations in traditional fee-for-
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service programs.  Findings from this study and previous studies have documented that 
more states are including more of those with significant medical needs in their managed 
care populations.  With this shift, it will be important to evaluate the degree to which 
managed care programs can effectively meet the needs of these populations, as well as to 
assess whether different quality improvement strategies are more effective with these 
different populations. One may find, for example, that while less intensive interventions, 
such as public reporting, may be sufficient to improve care in low-income populations, 
more intensive and more costly interventions (such as state-wide collaborative and P4P 
incentives) may be necessary to improve care in a disabled population.   
Finally, research on quality improvement at a health plan or Medicaid agency 
level has typically focused on populations that are enrolled in managed care programs.  
However, the findings from this study indicate that the quality programs of slightly over 
half (52%) of the states responding had oversight over both their managed care and their 
fee-for-service programs.  Quality improvement activities in a non-managed care 
program can be more difficult without external organizations that are contracted and 
accountable for providing care.  It would be interesting for future research to look at what 
strategies states are using to evaluate and improve the quality in their non-managed care 
programs, how these efforts are integrated with their managed care programs, and how 
their effectiveness compares with those strategies used in a managed care environment.   
Recommendations  
Although CMS has established certain requirements for all states to meet 
regarding implementation of a quality strategy for their managed care programs, these 
requirements have not been structured in such a way that they allow meaningful 
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comparisons between state Medicaid programs, or easily allow states to learn from each 
others successes and failures.  With virtually all states that have managed care programs 
utilizing some HEDIS measures, CMS easily could begin to develop comparative 
measures by establishing a core set of performance measures that all states would capture 
and report.  States could elect to report on additional standardized measures (from a finite 
set) based upon their populations in managed care, and the areas that they have identified 
as important for their state. A central Medicaid quality website could be established that 
would report state data on these core measures in the same way that NCQA and many 
states now report such data from individual health plans.  This would allow states to 
benchmark their performance against other states, set improvement goals, and measure 
their performance over time.  Such a site also would allow Medicaid agencies to share 
tools and better practices, as well as to enhance collaboration with each other. 
Along with improving the collection and reporting of standard performance 
measures, it also will be important for states to improve their assessment of the quality of 
preventive and developmental services delivered to children.  While children make up a 
significant proportion of Medicaid beneficiaries, particularly within managed care 
programs, and Early Periodic Screening, Diagnostic, and Treatment services (EPSDT) 
are federally mandated, Ireys et al (2005) found that few states did much more than 
assess the number of children receiving services and counting the number of visits 
received.   This is consistent with the findings of the current study which the most 
commonly reported performance measures assessing the number of children receiving a 
well child visit.  However, about half (48%) of the states surveyed reported that they also 
used some other means to assess the quality of developmental services, such as medical 
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record reviews, focus groups, or member surveys.   While this is encouraging, the 
development of standard measures and methods of assessment that specifically focus on 
the provision of preventive and developmental services would assist state agencies in 
collecting this information, and doing so in way that would allow comparative evaluation, 
as well as aggregation of information across states.  
  Finally, although the focus of the study was on beneficiaries in managed care 
plans, it is noteworthy that while 52% of the responding states indicated that their quality 
programs had oversight over both managed care and fee-for-service programs, 48% of 
the states’ quality programs only reviewed their managed care programs.  While the Code 
of Federal Regulations requires that states with managed care programs develop and 
implement a quality strategy, there is no such requirement for traditional (fee-for-service 
Medicaid).  While not directly assessed by this study, the findings suggest that in many 
states an organized program focused on improving quality does not exist for members in 
traditional Medicaid.   With approximately 35% of Medicaid beneficiaries continuing to 
receive care through non-managed care programs (including many of the populations 
with the greatest medical need), it will be important to broaden the scope of the quality 
strategy to include all Medicaid recipients.  This will ensure that state efforts toward 
quality improvement are directed and prioritized across their entire population and that 
resources for quality efforts are appropriately targeted based on an overall strategy, rather 
than one focused solely on managed care. 
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APPENDIX B. – COVER LETTER TO MEDICAID DIRECTORS 
We are requesting your participation in a survey that is being conducted by Georgia State 
University and the Georgia Department of Medical Assistance Plans.  We are evaluating 
the various approaches that state Medicaid agencies are taking to assure and improve the 
quality of care that their recipients receive through managed health care organizations.  A 
primary objective of this project is to determine the approaches that are being used to 
improve quality, and the degree to which these approaches can be used to assess quality 
outcomes. 
 
We are asking you to complete a web based survey that asks a variety of questions about 
your quality program and oversight of Medicaid managed care organizations. The survey 
consists primarily of checkbox responses and should take no more than 10 to 15 minutes 
of your time. Your participation in this survey is voluntary and individual responses will 
be kept confidential. If you would like to receive a report of the results you can submit 
your contact information at the end of the survey and we will send you a summary of our 
findings. 
          
We are asking that one person from each state Medicaid program respond to this survey 
by 1/30/2009. Ideally this will be the person most knowledgeable about your Medicaid 
quality program.  The survey can be accessed at 
https://www.psychdata.com/s.asp?SID=126601 
         
If you have any questions about this study please contact Dev Nair, PhD at 
dnair3@student.gsu.edu. 
 
